“…Treatment with the D2-preferring receptor antagonists pimozide (Beninger and Hahn, 1983;Beninger and Herz, 1986), haloperidol [4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one], raclopride, or sulpiride (Fontana et al, 1993;Dias et al, 2006 but see Cervo and Samanin, 1996), but not metoclopramide (Mazurski and Beninger, 1991), given during the conditioning phase, prevented the acquisition of conditioned activity. However, during the expression test, pimozide (Beninger and Hahn, 1983;Beninger and Herz, 1986) and raclopride (Fontana et al, 1993 but see Cervo and Samanin, 1996) failed to block the expression of conditioned activity.…”